Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in Seasonal Allergic Rhinitis
2015-004873-34Phase 4
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone in seasonal allergic rhinitis (SAR) (2 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in nighttime symptoms score (NSS).
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2015-004873-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004873-34.